HALPER SADEH LLC ENCOURAGES ADAPTHEALTH CORP. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
AHCOShareholders should contact the firm immediately as there may be limited time to enforce your rights. NEW YORK, Dec. 5, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of AdaptHealth Corp. (NASDAQ: AHCO) breached...
AdaptHealth Corp. Announces Upgraded S&P Global Issue-Level Rating on Senior Unsecured Debt
AHCOCONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that S&P Global Ratings has recently upgraded its issue-level rating on the Company’s senior unsecured debt to ‘BB-’ from ‘B+’ and revised its recovery rating to ‘4’ from ‘5.’ S&P Global Ratings highlighted that the upgr
AdaptHealth Corp. Announces Second Quarter 2025 Results
AHCOCONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today financial results for the second quarter ended June 30, 2025. Second Quarter Results and Highlights All comparisons are to the quarter ended June 30, 2024 unless otherwise stated. Net revenue was $800.4 million compared to $806.
AdaptHealth Corp. Partners With a Major National Healthcare System to Become the Exclusive Provider of Home Medical Equipment
AHCOCONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, today announced that it has entered into a definitive agreement with a major national healthcare system. Under the agreement, AdaptHealth will serve as the exclusive provider of home medical equipment and supplies across the healthcare system’s
AdaptHealth Corp. to Participate in Upcoming Investor Conference
AHCOPLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the Canaccord Genuity 45th Annual Growth Conference, being held in Boston, on Wednesday, August 13, 2025, including a fireside chat at 8:00am ET. The webcast link will be available on the Compan
Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $13
AHCORBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $13
AHCOAdaptHealth Lowers FY2025 Sales Guidance From $3.22B-$3.36B To $3.18B-$3.32B Vs $3.27B Est; Sees Adjusted EBITDA Of $665M To $705M (Prior $670M To $710M)
AHCOAdaptHealth Q1 EPS $(0.05) Misses $0.04 Estimate, Sales $777.88M Beat $764.77M Estimate
AHCOBaird Maintains Outperform on AdaptHealth, Raises Price Target to $16
AHCO4 Analysts Assess AdaptHealth: What You Need To Know
AHCOCanaccord Genuity Maintains Buy on AdaptHealth, Raises Price Target to $14
AHCORBC Capital Maintains Outperform on AdaptHealth, Raises Price Target to $14
AHCOTruist Securities Maintains Buy on AdaptHealth, Raises Price Target to $14
AHCODow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings
AHCOItron Posts Upbeat Results, Joins AdaptHealth, EverQuote, Goosehead Insurance And Other Big Stocks Moving Higher On Tuesday
AHCOAdaptHealth Q4 2024 GAAP EPS $0.34 Beats $0.27 Estimate, Sales $856.65M Beat $829.19M Estimate
AHCOAdaptHealth Sees FY2025 Sales $3.220B-$3.360B vs $3.33B Est
AHCOAdaptHealth Q4 Sales $856.65M Beat $829.19M Estimate
AHCOUBS Maintains Buy on AdaptHealth, Lowers Price Target to $11
AHCORBC Capital Maintains Outperform on AdaptHealth, Lowers Price Target to $11
AHCOTruist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $12
AHCOThese Analysts Lower Their Forecasts On AdaptHealth Following Weak Sales
AHCOUBS Maintains Buy on AdaptHealth, Lowers Price Target to $12
AHCOCanaccord Genuity Maintains Buy on AdaptHealth, Lowers Price Target to $13
AHCOBaird Maintains Outperform on AdaptHealth, Lowers Price Target to $14
AHCOAdaptHealth Revises FY24 Net Revenue Outlook From $3.255B - $3.315B To $3.220B - $3.260B, (Est $3.276B)
AHCOAdaptHealth Q3 Sales $805.86M Miss $809.30M Estimate
AHCO